While the reduction in price target from $16 to $14 by Goldman Sachs could be seen as a negative signal, the maintenance of a Buy rating suggests that the analyst still sees positive potential in NOVA's stock. This mixed signal might lead to short-term uncertainty among investors, potentially causing minor fluctuations in the stock price. However, the continued endorsement from a reputable analyst could help maintain investor confidence in the longer term.